{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:38:16Z","timestamp":1778632696834,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K08517"],"award-info":[{"award-number":["22K08517"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Cancer Research and Development Fund","award":["2023-A-16"],"award-info":[{"award-number":["2023-A-16"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12185-025-03973-7","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T14:51:14Z","timestamp":1743087074000},"page":"257-266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Oral beclomethasone dipropionate therapy and prognostic plasma biomarkers for gastrointestinal graft-versus-host disease"],"prefix":"10.1007","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4881-0427","authenticated-orcid":false,"given":"Yoshihiro","family":"Inamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumu","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihisa","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asako","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigehisa","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Kusaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Aruga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Maezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chitose","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"issue":"22","key":"3973_CR1","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMra1609337","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser R, Blazar BR. Acute graft-versus-host disease - biologic process, prevention, and therapy. N Engl J Med. 2017;377(22):2167\u201379.","journal-title":"N Engl J Med"},{"issue":"8","key":"3973_CR2","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.bbmt.2012.04.005","volume":"18","author":"PJ Martin","year":"2012","unstructured":"Martin PJ, Rizzo JD, Wingard JR, et al. First and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transpl. 2012;18(8):1150\u201363.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"5","key":"3973_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.bbmt.2003.12.304","volume":"10","author":"PJ Martin","year":"2004","unstructured":"Martin PJ, McDonald GB, Sanders JE, et al. Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transpl. 2004;10(5):320\u20137.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"2","key":"3973_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3324\/haematol.2013.093062","volume":"99","author":"Y Inamoto","year":"2014","unstructured":"Inamoto Y, Martin PJ, Storer BE, Mielcarek M, Storb RF, Carpenter PA. Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease. Haematologica. 2014;99(2):385\u201391.","journal-title":"Haematologica"},{"issue":"4","key":"3973_CR5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.bbmt.2015.01.001","volume":"21","author":"ML MacMillan","year":"2015","unstructured":"MacMillan ML, Robin M, Harris AC, et al. A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality. Biol Blood Marrow Transplant. 2015;21(4):761\u20137.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"26","key":"3973_CR6","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1182\/blood-2009-12-258442","volume":"115","author":"ML MacMillan","year":"2010","unstructured":"MacMillan ML, DeFor TE, Weisdorf DJ. The best endpoint for acute GVHD treatment trials. Blood. 2010;115(26):5412\u20137.","journal-title":"Blood"},{"issue":"1","key":"3973_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/bmt.2011.41","volume":"47","author":"RM Saliba","year":"2012","unstructured":"Saliba RM, Couriel DR, Giralt S, et al. Prognostic value of response after upfront therapy for acute GVHD. Bone Marrow Transpl. 2012;47(1):125\u201331.","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"3973_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0016-5085(98)70361-0","volume":"115","author":"GB McDonald","year":"1998","unstructured":"McDonald GB, Bouvier M, Hockenbery DM, et al. Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial. Gastroenterology. 1998;115(1):28\u201335.","journal-title":"Gastroenterology"},{"issue":"10","key":"3973_CR9","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1182\/blood-2006-05-021139","volume":"109","author":"DM Hockenbery","year":"2007","unstructured":"Hockenbery DM, Cruickshank S, Rodell TC, et al. A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease. Blood. 2007;109(10):4557\u201363.","journal-title":"Blood"},{"issue":"11","key":"3973_CR10","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1097\/00007890-199512000-00010","volume":"60","author":"PH Baehr","year":"1995","unstructured":"Baehr PH, Levine DS, Bouvier ME, et al. Oral beclomethasone dipropionate for treatment of human intestinal graft-versus-host disease. Transplantation. 1995;60(11):1231\u20138.","journal-title":"Transplantation"},{"issue":"8","key":"3973_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/sj.bmt.1705489","volume":"38","author":"Y Miura","year":"2006","unstructured":"Miura Y, Narimatsu H, Kami M, et al. Oral beclomethasone dipropionate as an initial treatment of gastrointestinal acute graft-versus-host disease after reduced-intensity cord blood transplantation. Bone Marrow Transpl. 2006;38(8):577\u20139.","journal-title":"Bone Marrow Transpl"},{"issue":"12","key":"3973_CR12","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s00277-015-2483-z","volume":"94","author":"H Yamamoto","year":"2015","unstructured":"Yamamoto H, Uchida N, Uchida Y, et al. Oral beclomethasone dipropionate as an initial treatment for stages 1\u20132 gastrointestinal tract acute graft-versus-host disease following unrelated cord blood transplantation. Ann Hematol. 2015;94(12):2073\u20135.","journal-title":"Ann Hematol"},{"issue":"6","key":"3973_CR13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMoa1213299","volume":"369","author":"MT Vander Lugt","year":"2013","unstructured":"Vander Lugt MT, Braun TM, Hanash S, et al. ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. N Engl J Med. 2013;369(6):529\u201339.","journal-title":"N Engl J Med"},{"issue":"1","key":"3973_CR14","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2352-3026(14)00035-0","volume":"2","author":"JE Levine","year":"2015","unstructured":"Levine JE, Braun TM, Harris AC, et al. A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study. Lancet Haematol. 2015;2(1):e21-29.","journal-title":"Lancet Haematol"},{"issue":"25","key":"3973_CR15","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1182\/blood-2018-01-822957","volume":"131","author":"H Major-Monfried","year":"2018","unstructured":"Major-Monfried H, Renteria AS, Pawarode A, et al. MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD. Blood. 2018;131(25):2846\u201355.","journal-title":"Blood"},{"key":"3973_CR16","doi-asserted-by":"publisher","first-page":"204062071989135","DOI":"10.1177\/2040620719891358","volume":"10","author":"HK Srinagesh","year":"2019","unstructured":"Srinagesh HK, Levine JE, Ferrara JLM. Biomarkers in acute graft-versus-host disease: new insights. Ther Adv Hematol. 2019;10:2040620719891358.","journal-title":"Ther Adv Hematol"},{"issue":"12","key":"3973_CR17","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1182\/blood-2011-10-387357","volume":"119","author":"AC Harris","year":"2012","unstructured":"Harris AC, Ferrara JL, Braun TM, et al. Plasma biomarkers of lower gastrointestinal and liver acute GVHD. Blood. 2012;119(12):2960\u20133.","journal-title":"Blood"},{"issue":"6","key":"3973_CR18","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1182\/blood-2011-02-334821","volume":"118","author":"T Luft","year":"2011","unstructured":"Luft T, Dietrich S, Falk C, et al. Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system. Blood. 2011;118(6):1685\u201392.","journal-title":"Blood"},{"issue":"1","key":"3973_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/bmt.2008.419","volume":"44","author":"Y Inamoto","year":"2009","unstructured":"Inamoto Y, Ito M, Suzuki R, et al. Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy. Bone Marrow Transpl. 2009;44(1):43\u20139.","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"3973_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbmt.2012.09.018","volume":"19","author":"S Dietrich","year":"2013","unstructured":"Dietrich S, Falk CS, Benner A, et al. Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment. Biol Blood Marrow Transpl. 2013;19(1):22\u20137.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"6","key":"3973_CR21","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, et al. Consensus conference on acute GVHD grading. Bone Marrow Transpl. 1995;15(6):825\u20138.","journal-title":"Bone Marrow Transpl"},{"issue":"7","key":"3973_CR22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/phar.2944","volume":"44","author":"BJ Haan","year":"2024","unstructured":"Haan BJ, Blackmon SN, Cobb AM, et al. Corticosteroids in critically ill patients: a narrative review. Pharmacotherapy. 2024;44(7):581\u2013602.","journal-title":"Pharmacotherapy"},{"issue":"7","key":"3973_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1053\/bbmt.2002.v8.pm12171485","volume":"8","author":"ML MacMillan","year":"2002","unstructured":"MacMillan ML, Weisdorf DJ, Wagner JE, et al. Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems. Biol Blood Marrow Transpl. 2002;8(7):387\u201394.","journal-title":"Biol Blood Marrow Transpl"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-03973-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-03973-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-03973-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T08:08:07Z","timestamp":1757146087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-03973-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["3973"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-03973-7","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"17 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Y.I. and H.M. are lead reviewers of the International Journal of Hematology. Y.I. reports personal fees from Novartis, Janssen, and Meiji Seika Pharma outside the submitted work. K.W. is a stockholder and a board member as a co-founder of ARC Therapies Corp. Other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}